General description

Trilogy^® Pretreatment Solution is intended to be used for immunohistochemical assays on formalin-fixed, paraffin-embedded (FFPE) tissue sections. Using this product eliminates the need for multiple solutions to deparaffinize, rehydrate, and antigen retrieve FFPE tissue samples.¹ The use of a single solution allows for a standardized pretreatment protocol that produces consistent and reliable results when used in conjunction with Cell Marque Primary Antibodies.

1. Aghassi et al. (2003). Composition and Method for Treating Tissue Samples (U.S. Patent No. 6,649,368). U.S. Patent and Trademark Office. https://rb.gy/gy42ef

Quality

Note: This product is similar in use to Trilogy^® Pretreatment Solution (920P series products) but does not contain IGEPAL^® CA-630 and complies with European Union (EU) Regulation (EC) No 1907/2006, REACH.

Physical form

Solution containing pretreatment reagents.

Preparation Note

Download the IFU specific to your product lot and format
Note: This requires a keycode which can be found on your packaging or product label.

Other Notes

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

Legal Information

IGEPAL is a registered trademark of Solvay

Trilogy is a registered trademark of Cell Marque Corporation

description: For In Vitro Diagnostic Use in Select Regions. Quality Level: 100, 500. form: aqueous solution. packaging: pkg of 1 . L ready-to-use (922P-09), pkg of 200 . mL concentrated 20x (922P-06), pkg of 200 . mL ready-to-use (922P-05), pkg of 240 . mL concentrated 100x (922P-07), pkg of 50 . mL concentrated 20x (922P-04). manufacturer/tradename: Cell Marque. technique(s): immunohistochemistry: suitable. storage temp.: 20-25Â°C. Storage Class Code: 12 - Non Combustible Liquids. WGK: WGK 2. Flash Point(F): Not applicable. Flash Point(C): Not applicable.